Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin (Q40881685)

24 September 2017

title

Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin (English)

1 reference

24 September 2017

1

1 reference

24 September 2017

2

1 reference

24 September 2017

Pensa T

3

1 reference

24 September 2017

Gambetta RA

4

1 reference

24 September 2017

Nasini G

5

1 reference

24 September 2017

Cuccuru G

6

1 reference

24 September 2017

Cassinis M

7

1 reference

24 September 2017

Pratesi G

8

1 reference

24 September 2017

Polizzi D

9

1 reference

24 September 2017

Tortoreto M

10

1 reference

24 September 2017

Zunino F

11

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

24 September 2017

published in

Biochemical Pharmacology

1 reference

24 September 2017

volume

59

1 reference

24 September 2017

issue

12

1 reference

24 September 2017

page(s)

1539-1547

1 reference

Receptor protein-tyrosine kinases and their signal transduction pathways

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Identification and biochemical characterization of p70TRK, product of the human TRK oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Tyrosine kinase receptor indistinguishable from the c-met protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Tyrosine kinase inhibition: an approach to drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

RET mutations in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Non-amine based analogues of lavendustin A as protein-tyrosine kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Structure elucidation of clavilactone D: an inhibitor of protein tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Secondary mould metabolites. Part 47. Isolation and structure elucidation of clavilactones A–C, new metabolites from the fungus Clitocybe clavipes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Cytoskeletal and morphological changes associated with the specific suppression of the epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

The GTPase superfamily: conserved structure and molecular mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

New colorimetric cytotoxicity assay for anticancer-drug screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

AGAR SUSPENSION CULTURE FOR THE SELECTIVE ASSAY OF CELLS TRANSFORMED BY POLYOMA VIRUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

Inhibition of protein-tyrosine kinases by tyrphostins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900278-1

10.1016/S0006-2952(00)00278-1

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference